Neurology® has published three AAN evidence-based practice guidelines on the use of botulinum neurotoxin (BoNT) for various indications, including:
The guidelines, published in the May 6 edition of the journal, find that BoNT is possibly effective for low back pain, and probably ineffective for relief of tension type headache and episodic migraine. The guideline authors performed a rigorous systematic review of the literature on the use of botulinum neurotoxin for the disorders. There is high quality data for use of BoNT for spasticity, and it is possibly useful in the treatment of essential tremor and pain.
Read the new guidelines, press release, listen to the radio news release, access clinician and patient summaries, and read the case studies.
Press release (.pdf)
Radio News Release (.mp3)